Hansoh Pharmaceutical Group Company Limited(HK:3692)
HK$34.94+0.58 (+1.69%)
HK:3692
Hansoh Pharmaceutical Group Company Limited financials statements
HK$34.94
At close:+0.58 (+1.69%)
Want to see HK:3692 full AI Analyst Report?
Hansoh Pharmaceutical Group Company Limited (3692) Financial Statements
8 Followers
Hansoh Pharmaceutical Group Company Limited Financial Overview
Hansoh Pharmaceutical Group Company Limited's market cap is currently ¥208.36B. The company's EPS TTM is ¥1.10; its P/E ratio is 27.02; and it has a dividend yield of 1.39%. Hansoh Pharmaceutical Group Company Limited is estimated to report earnings on March 30, 2027, and the estimated EPS forecast is ¥0.57. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 15.03B | ¥ 12.26B | ¥ 10.10B | ¥ 9.38B | ¥ 9.94B |
| Gross Profit | ¥ 13.51B | ¥ 11.16B | ¥ 9.07B | ¥ 8.51B | ¥ 9.06B |
| Operating Income | ¥ 5.42B | ¥ 4.03B | ¥ 2.84B | ¥ 2.67B | ¥ 2.90B |
| EBITDA | ¥ 5.79B | ¥ 4.30B | ¥ 4.20B | ¥ 2.94B | ¥ 3.08B |
| Net Income | ¥ 5.56B | ¥ 4.37B | ¥ 3.28B | ¥ 2.58B | ¥ 2.71B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 31.58B | ¥ 23.39B | ¥ 24.86B | ¥ 21.63B | ¥ 18.94B |
| Total Assets | ¥ 39.92B | ¥ 31.66B | ¥ 33.04B | ¥ 30.00B | ¥ 27.16B |
| Total Debt | ¥ 105.14M | ¥ 117.89M | ¥ 4.30B | ¥ 4.38B | ¥ 3.83B |
| Net Debt | ¥ -3.31B | ¥ -22.50B | ¥ -18.13B | ¥ -13.24B | ¥ -10.87B |
| Total Liabilities | ¥ 4.54B | ¥ 2.98B | ¥ 7.24B | ¥ 7.35B | ¥ 7.13B |
| Stockholders' Equity | ¥ 35.38B | ¥ 28.68B | ¥ 25.79B | ¥ 22.65B | ¥ 20.03B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 6.25B | ¥ 3.64B | ¥ 2.90B | ¥ 2.47B | ¥ 2.12B |
| Operating Cash Flow | ¥ 6.74B | ¥ 3.86B | ¥ 3.12B | ¥ 2.74B | ¥ 2.58B |
| Investing Cash Flow | ¥ -7.15B | ¥ -1.39B | ¥ 1.07B | ¥ -5.94B | ¥ -2.26B |
| Financing Cash Flow | ¥ 1.55B | ¥ -6.07B | ¥ -753.70M | ¥ -818.14M | ¥ 3.42B |
Currency in CNY
